miR-122在非酒精性脂肪肝病中的诊断价值

被引：5

作者：

黄惠强

邓燕君

刘新霞

机构：

[1] 中山市疾病预防控制中心

来源：

热带医学杂志 | 2017年 / 17卷 / 02期

关键词：

非酒精性脂肪肝病; miR-122; 特异性表达;

D O I：

暂无

中图分类号：

R575.5 [肝代谢障碍];

学科分类号：

1002 ; 100201 ;

摘要：

目的分析miR-122对非酒精性脂肪性肝病(NAFLD)的诊断价值及对预后的影响,探讨其临床意义。方法选取2014年7月至2016年1月期间于中山市疾病预防控制中心就诊的94例NAFLD患者,根据超声肝脏回声的强度分为正常组、轻度变性组、重度变性组,同时收集25例非NAFLD患者的体检人员作为对照组,抽取血清提取RNA,采用q RT-PCR检测miR-122的表达,分析miR-122的表达及对疾病的诊断价值。结果 NAFLD患者血清miR-122的表达水平(M=3.81×10-3)明显低于对照组(M=0.042)(P<0.05);轻度变性和重度变性NAFLD患者血清miR-122表达水平均低于正常组患者,且随着脂肪变性程度的加重,miR-122的表达水平呈降低的趋势(P<0.05);miR-122对NAFLD诊断的AUC值为0.826。结论 NAFLD患者血清miR-122表达下降,miR-122对NAFLD具有潜在诊断价值。

引用

页码：201 / 204

页数：4

共 17 条

[1]

Comments on"The Effects of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease". Cheraghpour M,Hekmatdoost A,Ghaemi A. Hepat Mon . 2016

[2]

Data on differentially expressed micro RNAs in the liver between nonalcoholic fatty liver disease and normal Wistar rat using Solexa sequencing. Zhang D,Wang Y,Ji Z,et al. Data Brief . 2016

[3]

Cyclin G1 is a target of miR-122a,a microRNA frequently down-regulated in human hepatocellular carcinoma. Gramantieri L,Ferracin M,Fornari F,et a1. Cancer Research . 2007

[4]

Impact of circulating mi R-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan. Akuta,N,Kawamura,Y,Suzuki,F,Saitoh,S,Arase,Y,Kunimoto,H,Sorin,Y,Fujiyama,S,Sezaki,H,Hosaka,T.et al. Hepatol Int . 2016

[5] 氧化应激与非酒精性脂肪肝病的研究进展 [J].

林秋香 ;

周冬生 ;

梁志清 .

热带医学杂志, 2013, 13 (05) :657-660

[6] Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis [J].

Clarke, John D. ;

Sharapova, Tatiana ;

Lake, April D. ;

Blomme, Eric ;

Maher, Jonathan ;

Cherrington, Nathan J. .

JOURNAL OF APPLIED TOXICOLOGY, 2014, 34 (06) :726-732

[7]

Identification and differential expression of micro RNAs associated with fat deposition in the liver of Wistar rats with nonalcoholic fatty liver disease. Zhang D,Wang Y,Ji Z,et al. Gene . 2016

[8]

Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease[J] . Giovanni Musso,Roberto Gambino,Maurizio Cassader. &nbspAnnual Review of Medicine . 2010

[9]

MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease[J] . X. Jin,Y.-F. Ye,S.-H. Chen,C.-H. Yu,J. Liu,Y.-M. Li. &nbspDigestive and Liver Disease . 2008 (4)

[10]

MicroRNA-122 down-regulation is involved in phenobarbital-mediated activation of the constitutive androstane receptor. Shizu Ryota,Shindo Sawako,Yoshida Takemi,Numazawa Satoshi. PloS one . 2012

← 1 2 →